admin

With a steady 𝟏𝟎% 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞, the pharmaceutical sector continues to showcase resilience, innovation, and its vital role in strengthening healthcare access across the nation.

PPMA North Chairman Saad Javed Akram met Mr. Tahir Habib Cheema (Collector of Customs) for a constructive discussion on industry challenges and growth opportunities.

DRAP & SECP sign MoU for eService Portal integration. Signed by Dr. Obaidullah (CEO, DRAP) & Mr. Muzzafar Ahmed Mirza (Commissioner, SECP). Witnessed by Mr. Qaiser Ahmed Sheikh (Federal Minister & Chairman BOI).

DRAP has issued a rapid alert against falsified drug products, with spurious batches seized. PPMA supports this action to safeguard public health and ensure safe, quality medicines for all.

With evolving US tariffs, Pakistan’s pharmaceutical industry is well-positioned to capture larger market share, reinforcing its reputation for quality and affordability.

𝐏𝐚𝐤𝐢𝐬𝐭𝐚𝐧 𝐚𝐧𝐝 𝐂𝐡𝐢𝐧𝐚 unite to build an advanced antibiotic plant driving innovation, boosting healthcare, and shaping a healthier tomorrow. As proud members of PPMA, Citi Pharma’s milestone reflects the collective strength of Pakistan’s pharmaceutical industry in advancing global healthcare.

Pakistan’s pharmaceutical industry is making waves internationally, fueled by its high-quality manufacturing and a significant rise in exports. 💊📈 With growing interest from global companies, the sector is stepping confidently beyond borders and onto the world stage — a true testament to our industry’s dedication and innovation. ✨ Pakistan’s pharma is not just growing —

Pakistan Pharma continues to expand its global reach through key strategic partnerships that benefit both local industry and international markets. In a progressive move to deepen international collaboration, the Pakistan Pharmaceutical Manufacturer Association (PPMA) welcomed the establishment of the Pakistan–UK Business Advisory Council. This forum is set to enhance bilateral trade in pharmaceuticals and healthcare,

PPMA Leadership, led by key executive members, held a productive meeting with DRAP Additional Director Dr. Obaid Ali to discuss regulatory reforms, industry challenges, and future collaboration to uplift Pakistan’s pharmaceutical sector. This strategic meeting marks a significant development in the ongoing efforts to strengthen regulatory coordination in the pharma industry of Pakistan. With the